Detalhe da pesquisa
1.
Lipids as Targets for Renal Cell Carcinoma Therapy.
Int J Mol Sci
; 24(4)2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36834678
2.
The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.
Immunology
; 160(1): 10-23, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32020584
3.
Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.
J Neurochem
; 153(4): 510-524, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31618458
4.
IUBMB focused meeting: 10th conference Inhibitors of Protein Kinases. Kinase inhibitors in target biology and disease (IPK2019).
IUBMB Life
; 72(6): 1094-1096, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32441880
5.
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.
Nucleic Acids Res
; 46(D1): D1091-D1106, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29149325
6.
Notch Inhibition in Cancer: Challenges and Opportunities.
Chimia (Aarau)
; 74(10): 779-783, 2020 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33115560
7.
PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases.
Int J Mol Sci
; 20(22)2019 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31752127
8.
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.
Nucleic Acids Res
; 44(D1): D1054-68, 2016 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26464438
9.
Upregulation of the S1P3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE2 and EP2/EP4 activation.
Biochim Biophys Acta
; 1861(11): 1840-1851, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27616330
10.
International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands.
Pharmacol Rev
; 66(4): 918-47, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25026896
11.
Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate.
FASEB J
; 29(7): 2980-92, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25854701
12.
NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors.
Proc Natl Acad Sci U S A
; 110(47): E4437-45, 2013 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24191057
13.
25 years of small molecular weight kinase inhibitors: potentials and limitations.
Mol Pharmacol
; 87(5): 766-75, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25549667
14.
FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.
Cancer Cell
; 12(3): 201-14, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17785202
15.
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation.
Bioorg Med Chem Lett
; 23(13): 3741-8, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23726034
16.
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.
Cancer Cell
; 7(2): 129-41, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15710326
17.
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.
Nat Genet
; 36(5): 453-61, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15098032
18.
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes.
Br J Pharmacol
; 180 Suppl 2: S289-S373, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123154
19.
The Concise Guide to PHARMACOLOGY 2023/24: Transporters.
Br J Pharmacol
; 180 Suppl 2: S374-S469, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123156
20.
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors.
Br J Pharmacol
; 180 Suppl 2: S241-S288, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123155